Derm-Biome compound shows promise to prevent and treat squamous cell carcinoma in UV-induced skin cancer model
April 18, 2024
Derm-Biome Pharmaceuticals Inc. has developed a topical anticancer treatment for patients with or at high risk of developing multiple actinic keratoses.